• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Merck

Merck

Merck & Co Inc MRK 4 Star

Last Price$58.34Day Change (%)1.02%
Open Price$58.28Day Change ($)0.59
Day Range58.15–58.5452-Week Range52.49–63.62

As of Mon 3/30/2015 6:04:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Merck Announces New $10 Billion Share Repurchase Program

    Merck Announces New $10 Billion Share Repurchase Program

  2. Merck's stock gains after new $10 billion stock repurchase program announced

    Merck's stock gains after new $10 billion stock repurchase program announced

  3. Merck KGaA Hunting for Small Acquisitions, Says CEO -- Report

    Merck KGaA Hunting for Small Acquisitions, Says CEO -- Report

  4. FDA delays meeting on Merck's surgery drug

    FDA delays meeting on Merck's surgery drug

  5. Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer

    Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer

  6. Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of Anti-PD-1 Therapy with Multi-targeting RTK Inhibitor and Microtubule Dynamics Inhibitor in Multiple Types of Cancer

    Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of Anti-PD-1 Therapy with Multi-targeting RTK Inhibitor and Microtubule Dynamics Inhibitor in Multiple Types of Cancer

  7. New Cancer Drugs: First Movers Will Win

    First movers, including Bristol-Myers, and firms that can aggregate a portfolio of immuno-oncology therapies will be positioned well.

  8. Merck Increases Buyback Authorization by $10 Billion

    Merck Increases Buyback Authorization by $10 Billion

  9. UPDATE: Sonic shares rise after results top Street estimates

    UPDATE: Sonic shares rise after results top Street estimates

  10. FDA Cancels Panel Meeting on Merck Surgery Drug

    FDA Cancels Panel Meeting on Merck Surgery Drug

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.